In conclusion, we showed that the therapeutic effect of MG against HCC involves the downregulation of the AMPK/NF-κB pathway and MMPs, which in turn inhibit migration, invasion, and the EMT of tumor cells. This evidence concerns the gene NFKB1 and neoplasm.